HOME >> MEDICINE >> NEWS
Statins may inhibit calcium growth on aortic valve in the elderly

People who take statins may have at least 60 percent less aortic valve calcium than people who do not take statins, according to a University of Washington study in the March 30 edition of The Lancet.

"A large percentage of elderly people suffer from excess calcium in their aortic valve. Excessive calicum buildup can prevent the valve from opening normally. Because we currently have no way to treat them with medicine, heart surgery to replace the valve is the only solution when the buildup is severe. But it may well be that the use of statins could slow or inhibit development of the problem," says Dr. Kevin OBrien, an associate professor of medicine in the UW School of Medicines Division of Cardiology.

OBriens co-authors of the research letter include Drs. David Shavelle and Xue-Qiao Zhao, also from the UW Division of Cardology, and Drs. Junichero Takasu, Matthew J. Budoff and SongShou Mao, all of the Harbor-UCLA Research and Education Institute of Torrance, Calif.

It is already well known that statins cause improvement in arterial blockage and reduce the occurrence of major cardiovascular events. The question examined in the Lancet paper is whether they can help prevent aortic valvular sclerosis, which is thickening and calcification of the aortic valve. People with this condition are at higher risk for cardiovascular events and may eventually require surgery to replace the valve.

OBrien and colleagues looked at the records of 65 people who had undergone two electron beam computed tomography scans an average of two years apart. Of the group, 28 had been taking statins. People on statins had a 62 percent lower median rate of calcium accumulation.

The researchers say that because of study limitations, it is too early to recommend that people take statins to protect themselves from aortic valve calcium. However, larger studies of the question would be a good idea, OBrien said.

(Disclosure: OBrien has received speaki
'"/>

Contact: Walter Neary
wneary@u.washington.edu
206-685-3841
University of Washington
28-Mar-2002


Page: 1 2

Related medicine news :

1. Statins effective in long term, Nordic study suggests
2. Statins show early promise for treating multiple sclerosis
3. Statins and aspirin may protect against severe vision loss in elderly
4. Statins could reduce stroke risk by a third
5. International Study Finds Statins Raise Good Cholesterol, Wake Forest Physician Reports
6. HIV patients may be at risk of heart problems when taking protease inhibitor drugs
7. COX-2 inhibitors associated with blood pressure elevation
8. Older people get the big picture faster, and they are less inhibited
9. Stat5 protein inhibits spread of breast cancer cells
10. COX-2 inhibitor increases the risk of heart attack in elderly adults with no history of heart attack
11. More studies on risks and benefits of COX-2 inhibitors published in Archives of Internal Medicine

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Statins may inhibit calcium growth aortic valve the elderly

(Date:3/6/2015)... Follow us on LinkedIn – ... drug refers to testing of absorption, distribution, metabolism, and ... toxicity studies are clubbed together with ADME, it is ... on lowering costs and time during drug development are ... drug development model uses toxicity and efficacy testing in ...
(Date:3/6/2015)... USA (PRWEB) March 06, 2015 Parents ... the fatal reality of substance use disorders. School programs ... to be marginally successful. NOPE, or Narcotics Overdose Prevention ... nationwide, according to Healthline News on Feb. ... illicit and prescription opiate drugs, drug prevention proponents are ...
(Date:3/6/2015)... 06, 2015 Johnson & Johnson and ... on March 5, 2015 in Superior Court in the ... documents, a jury of 12 awarded Mrs. Perry $700,000 ... implanted with an Ethicon TVT Abbrevo plastic sling for ... three women also awarded $5 million in punitive damages. ...
(Date:3/6/2015)... DC (PRWEB) March 06, 2015 Magellan ... nation’s only comprehensive source for key trends and statistics ... spend, medical injectables. Executives from Magellan Rx Management will ... Trend Report: Discover Your Hidden Specialty Drug Spend,” a ... Information Services, Inc. , Specialty drug spend makes up ...
(Date:3/6/2015)... 06, 2015 The Gluten-Free Certification ... Association, is pleased to announce that Dufflet Pastries, ... has expanded their product line of gluten-free treats ... scrumptious and as satisfying as any of their ... and never contains hydrogenated fats or oils, artificial ...
Breaking Medicine News(10 mins):Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:A Harbor Village Detox Clinical Psychologist Encourages School Programs like NOPE to Positively Impact Awareness of Substance Use Disorders 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3Health News:Atlantic Information Services, Magellan Rx Management Partner on Complimentary Webinar Outlining Key Findings of New Medical Pharmacy Trend Report 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 2Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 3Health News:Dufflet Pastries® Impressive Collection of Brownies, Cakes, Pies and Cakelets® Now Includes a Gluten-Free Line Certified By the GFCP. 4
(Date:3/6/2015)... WILMINGTON, Del. , March 6, 2015 /PRNewswire/ ... Patent and Trademark Office,s publication of U.S. Patent ... Eating Disorder."  The ,249 Patent Application features claimed methods ... may be used to treat Binge Eating Disorder ... "information material," or "flyer or an advertisement," as ...
(Date:3/5/2015)... , March 5, 2015 BioLineRx (NASDAQ: ... biopharmaceutical company dedicated to identifying, in-licensing and developing ... commenced an underwritten public offering of American Depositary ... Ordinary Shares. All of the ADSs in the ... JMP Securities is acting as sole ...
(Date:3/5/2015)... 5, 2015  IRIDEX Corporation (Nasdaq: IRIX ) ... ended January 3, 2015.  , Revenues were $11.8 ... the Company and up 11% from $10.6 million in the ... a record, up 12% from $38.3 million in 2013. ... up from 48.6% in the fourth quarter of the prior ...
Breaking Medicine Technology:Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8
Cached News: